In vitro metabolism of fenofibric acid by carbonyl reducing enzymes
Anti-inflammatory activity of anti-hyperlipidemic drug, fenofibrate, and its phase-I metabolite fenofibric acid: in silico, in vitro, and in vivo studies
Tags: Antara®, apoprotein CIII reducer, fibrate, hypercholesterolemia, hypertriglyceridemia, lipoprotein lipase activator, lower cholesterol, peroxisome proliferator-activated receptor alpha (PPARα), Triglide®, Trilipix®
BASi Method Number SAP.849
Sign up and you’ll receive the latest updates that matter to you, delivered straight to your inbox.
